해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트

 

구분	보고서(영문)
제약/ 바이오/ 임상시험 (11건)	AbbVie’s Humira Loss of Exclusivity Has Been a Missed Opportunity for Competitors
	J&J Forecast to Dominate BiTE Market
	2-SUCCEED Trial Sheds Positive Light on SC0062 for IgAN
	Small but Mighty, mRNA Vaccines Enter H5N1
	J&J’s Carvykti to Make a Meteoric Rise in Multiple Myeloma
	Pipeline Power: Sionna’s AbbVie Deal Could Redefine CF Therapeutics
	Paratek’s Nuzyra Exhibits Continued Clinical Success Following Phase III Study
	NewAmsterdam’s Obicetrapib Holds Potential to Become First CETP Inhibitor to Advance to Clinical Practice
	Viking Therapeutics’s New Dual GLP-1R/GIPR Agonist Expected to Start Phase III Clinical Trials Soon
	Novo’s Growth Faces Challenges Despite GLP-1 Receptor Agonist Obesity Boom
	Clinical Trials: Psychedelic Therapeutics
컨퍼런스/ 심포지엄/ 학회/ 기타 (3건)	The US Biosecure Act Threatens to Destabilize the Pharmaceutical Industry
	FDA’s Diversity Action Plan May Set a New Paradigm for Trial Transparency
	Monthly Macroeconomic Forecast - July 2024
질환별 (11건)	Renal Cell Carcinoma (RCC): Epidemiology Forecast to 2033
	Spinal Muscular Atrophy Market Expected to Reach $3.0 Billion Across the 7MM by 2033
	US Study Explores Racial Disparities in the Treatment of Type 2 Diabetes
	High Caseload of Dengue in New York and New Jersey
	Multiple Myeloma Eight-Market Drug Forecast
	Irregular Sleeping Pattern Increases the Risk of Type 2 Diabetes
	Alcoholic Hepatitis: Competitive Landscape
	Non-Hodgkin’s Lymphoma Trials Increase Over Past 5 Years
	New AI Model Boosts Early Osteoporosis Diagnosis for Aging Populations
	Migraine: Epidemiology Forecast to 2033
	US Launches Campaign to Address Racial Disparities in Lung Cancer Biomarker Testing